Pharma is Spending More on DTC Advertising But Its Effectiveness is Decreasing, Says New...
“The DTC Attitudes, Behaviors, and Preferences Survey” conducted by Health Stories Project – Insights (HSPi) and published within the eyeforpharma Whitepaper “The Great DTC Shake-Up: Patient perspectives on direct-to-consumer advertising” in...
Who Is the Most “Fantastic” Person Trump Has in Mind to Lead the FDA?
In a recent email, STAT: The Readout asked "Who's the next Mr. (or Ms.) Fantastic?":
"President Trump has a 'fantastic person' in mind to nominate as his new FDA commish. While we...
DTC Drug Ads Are Effective, But Confusing to Patients Say Physicians
Results from a new "microsurvey" (N = 319) performed by InCrowd, a provider of real-time market intelligence to the life sciences and healthcare firms, reveal "perhaps surprising" U.S. healthcare provider (HCP)...
PhRMA Should Have Listened to THIS “Guy in a Hoodie”
Back in December, 2015, year I suggested that the pharmaceutical industry put some distance between it a "Pharma Bro" Martin Shkreli. I said (here):
"Frankly, I'm getting tired of it all. Shkreli...
Pfizer’s New Viagra TV Ad Has a Unique Mobile “Call to Action”
As reported by FiercePharma (here), Pfizer’s new TV commercial for Viagra, which encourages patients to text a keyword from their mobile phones to receive special discounts, appears to be "a first"...
Does FDA Guidance About Pharma Communications with Payors Open a Path to Off-Label Discussions?
At the November, 2016, FDA public hearing on off-label promotion, representatives of the drug industry made a case for allowing companies to inform payers of off-label uses of their products.
Payers “play...
Fact Checking Puzzling Criticisms of a “Puzzling” DTC Study Proposed by FDA
I get periodic emails from Bob Ehrlich, Chairman of DTC Perspectives, Inc., giving his opinion on various direct-to-consumer (DTC) advertising issues.
Although I often do not agree with Ehrlich on many issues,...
Top Pharma Companies on Facebook
Back in August, 2011, Facebook opened up comments on ALL pharma pages, which meant that the pharmaceutical industry no longer was able to shut off comments on their product-related pages. Consequently,...
FDA Study is Designed to Justify a New BadAd Program for Consumers, IMHO
The FDA plans to do two new studies supposedly to gauge the “ability of consumers and healthcare professionals (HCPs) to independently identify deceptive prescription drug promotion” (see the Federal Register Notice here).
A...
Pharmaguy’s Top Five 2017 New Year’s Resolutions for the Pharma Industry
As is my tradition – as well as the tradition for many other editors/pundits – it’s time for me to tell pharma what I’d like to see included in its list...
